El mecanismo de accin principal involucra la activacin de receptores GLP-1 en mltiples tejidos, resultando en efectos metablicos beneficiosos para pacientes con diabetes tipo 2 y obesidad
Why are CheqUp treatments a subscription
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (Mounjaro) and chronic weight management (Zepbound)
Weight-loss drugs have seen a dramatic increase in prescriptions, driven by endorsements from celebrities and widespread reports of their health benefits
Many patients find that switching to semaglutide monotherapy provides superior, durable weight loss without phentermine's stimulant side effects (jitteriness, insomnia, elevated blood pressure)
At SmithRx, our approach is starkly different